We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App





Lab Tests Take Flight

By CLN Stat
Posted on 29 Jul 2019
Print article
(Photo courtesy of AACC)
(Photo courtesy of AACC)
A North Carolina medical facility has teamed up with national aviation, technology, and delivery service leaders to take part in the first medical drone delivery operation over a densely populated area of the United States, with a goal of improving patient care by speeding deliveries at a lower cost and expediting life-saving treatments.

Unmanned aviation drones deliver 10 times faster than ground transport, according to UPS, which has partnered with WakeMed Health & Hospitals in Raleigh, North Carolina, drone technology company Matternet, the Federal Aviation Administration (FAA), and North Carolina Department of Transportation (NCDOT) on this project. Since March, routine revenue flights have been taking place on the WakeMed campus under FAA and NCDOT oversight. Routine lab samples, which may include complete blood count and blood chemistry tests, liver function tests or cholesterol tests, travel by Matternet’s M2 Drone quadcopter from WakeMed Raleigh Medical Park’s outpatient clinic to WakeMed Raleigh Campus, its flagship hospital and site of the central pathology lab. Medical professionals load the sample encased in a secure container into the drone, and a remote pilot-in-command keeps track of each flight and troubleshoots any problems that arise.
Each drone is equipped with a parachute and other features to protect the samples in case of an emergency. However, the operators will either limit or pause drone flight in instances of high winds, ice, or rain.

Drone technology has the potential to transform health and healthcare delivery, Stuart Ginn, MD, WakeMed otolaryngologist and medical director for WakeMed Innovations, told CLN Stat. First-round test flights took place at WakeMed last summer, part of FAA’s 3-year Unmanned Aircraft System (UAS) Integration Pilot Program (IPP), which partners local governments with private sector companies to further investigate the commercial applications of drone technology.
“Our team has been working on UAS medical package delivery solutions for more than two years. We were thrilled when the FAA’s IPP was announced,” Ginn said. The application from WakeMed and its partners was one of 10 the FAA selected from a nationwide pool.

August 29, 2018, marked IPP’s first U.S. medical drone delivery test flight at WakeMed, in partnership with NCDOT’s Division of Aviation and Matternet. Following more than 100 test flights, UPS in March announced a new logistics service to deliver medical samples via unmanned drones. “This announcement, and the drone that took flight at WakeMed on March 26, was the next major milestone for unmanned aviation in the U.S., as it marked the first FAA-sanctioned use of a drone for routine revenue flights involving the transport of a product under a contractual delivery agreement,” explained Ginn.

Creating efficiencies in transporting routine blood and urine specimens is the initiative’s current focus. Courier vehicles will continue to transport items such as tissue samples from biopsies and pharmaceuticals although the partners are evaluating opportunities to move other items by UAS, such as pharmaceuticals, as the project expands. The ultimate goal is to build a network of UAS routes connecting all of the freestanding hospitals and healthplexes across the WakeMed system, according to Ginn. Next steps are to implement a UAS route connecting WakeMed’s Garner Healthplex to the WakeMed Raleigh Campus.

“The ability to work directly with regulators and technology leaders has allowed us to make tremendous progress,” Ginn said. “We’re proud to lead the way in developing this expertise for other healthcare systems who will use this technology in the future.”

Matternet may soon face some competition from other drone companies in the commercial space. Just recently, Wing, a subsidiary of Google parent Alphabet Inc. received FAA air carrier certification to deliver small commercial packages and has launched services in Virginia, with plans to expand. According to one news report, delivery items may include over-the-counter medications. The University of Maryland Medical Center (UMMC) in Baltimore also just announced that a drone flight had been used to deliver a kidney for transplant at UMMC.


Related Links:

AACC
Gold Member
Blood Gas Analyzer
GEM Premier 7000 with iQM3
Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
New
snRNP-C Test
Chorus snRNP-C Test
New
Gastrin-17 ELISA
Human Gastrin-17 CLIA Kit

Print article

Channels

Immunology

view channel
Image: Example image of the high-throughput microscopy method used in the study, showing immune cells stained with different fluorescence markers (Photo courtesy of Felix Kartnig/CeMM, MedUni Vienna)

Cutting-Edge Microscopy Technology Enables Tailored Rheumatology Therapies

Rheumatoid arthritis is the most common inflammatory joint disorder, with women three times as likely to suffer from the condition as men. Treatment advances made over the past decades have led to the... Read more

Microbiology

view channel
Image: RNA sequencing directly from whole blood aims to expand access to LRTI testing (Photo courtesy of CARB-X)

Novel Test to Diagnose Bacterial Pneumonia Directly from Whole Blood

Pneumonia and lower-respiratory-tract infections (LRTIs) are among the top causes of illness and death globally, particularly in vulnerable populations such as the elderly, young children, and immunocompromised... Read more

Pathology

view channel
Image: Lunit SCOPE HER2 is an AI-powered solution designed to detect HER2 expression profile (Photo courtesy of Lunit)

AI-Powered Pathology Solutions Accurately Predict Outcomes for HER2-Targeted Therapy in Metastatic CRC

A new study has highlighted how artificial intelligence (AI)-powered analysis of HER2 and the tumor microenvironment (TME) can improve patient stratification and predict clinical outcomes more effectively.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.